These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7275832)

  • 1. Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreus.
    Albers-Schönberg G; Joshua H; Lopez MB; Hensens OD; Springer JP; Chen J; Ostrove S; Hoffman CH; Alberts AW; Patchett AA
    J Antibiot (Tokyo); 1981 May; 34(5):507-12. PubMed ID: 7275832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    Alberts AW; Chen J; Kuron G; Hunt V; Huff J; Hoffman C; Rothrock J; Lopez M; Joshua H; Harris E; Patchett A; Monaghan R; Currie S; Stapley E; Albers-Schonberg G; Hensens O; Hirshfield J; Hoogsteen K; Liesch J; Springer J
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3957-61. PubMed ID: 6933445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of monacolin L from Aspergillus terreus cultures.
    Treiber LR; Reamer RA; Rooney CS; Ramjit HG
    J Antibiot (Tokyo); 1989 Jan; 42(1):30-6. PubMed ID: 2921224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of cyclic nonaketides to lovastatin and compactin by a lovC deficient mutant of Aspergillus terreus.
    Auclair K; Kennedy J; Hutchinson CR; Vederas JC
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1527-31. PubMed ID: 11412974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mevinolin: a highly specific inhibitor of microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase of radish plants.
    Bach TJ; Lichtenthaler HK
    Z Naturforsch C Biosci; 1982; 37(1-2):46-50. PubMed ID: 6917646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium.
    Hajjaj H; Niederberger P; Duboc P
    Appl Environ Microbiol; 2001 Jun; 67(6):2596-602. PubMed ID: 11375168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase.
    Endo A
    J Med Chem; 1985 Apr; 28(4):401-5. PubMed ID: 3981532
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of substrate supply in the regulation of cholesterol biosynthesis in rat hepatocytes.
    Pullinger CR; Gibbons GF
    Biochem J; 1983 Mar; 210(3):625-32. PubMed ID: 6870798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
    Boogaard A; Griffioen M; Cohen LH
    Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Endo A
    J Antibiot (Tokyo); 1980 Mar; 33(3):334-6. PubMed ID: 7380744
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase.
    Tobert JA; Hitzenberger G; Kukovetz WR; Holmes IB; Jones KH
    Atherosclerosis; 1982 Jan; 41(1):61-5. PubMed ID: 6918220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of plasma cholesterol by compactin and mevinolin.
    Nutr Rev; 1985 Sep; 43(9):266-8. PubMed ID: 3903562
    [No Abstract]   [Full Text] [Related]  

  • 15. Mevinolinic acid biosynthesis by Aspergillus terreus and its relationship to fatty acid biosynthesis.
    Greenspan MD; Yudkovitz JB
    J Bacteriol; 1985 May; 162(2):704-7. PubMed ID: 3988710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors.
    Bocan TM; Ferguson E; McNally W; Uhlendorf PD; Bak Mueller S; Dehart P; Sliskovic DR; Roth BD; Krause BR; Newton RS
    Biochim Biophys Acta; 1992 Jan; 1123(2):133-44. PubMed ID: 1739744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.